878
Participants
Start Date
September 1, 2015
Primary Completion Date
June 30, 2025
Study Completion Date
June 30, 2025
taxane plus carboplatin
"Doxorubicin (60 mg/m2) IV + cyclophosphamide (600 mg/m2) IV every 3 weeks for 4 cycles followed by taxane plus carboplatin for 4 cycles The taxane plus carboplatin regimen can be selected based on the investigator's discretion from among the following two regimens.~* Docetaxel (75 mg/m2) IV plus carboplatin (AUC 5) IV every 3 weeks for 4 cycles~* Paclitaxel (80 mg/m2) IV weekly for 12 doses plus carboplatin (AUC 5) IV every 3 weeks for 4 cycles"
Taxane
"Doxorubicin (60 mg/m2) IV + cyclophosphamide (600 mg/m2) IV every 3 weeks for 4 cycles followed by taxane for 4 cycles The taxane regimen can be selected at the investigator's discretion from among the following two regimens.~* Docetaxel (75 mg/m2) IV every 3 weeks for 4 cycles~* Paclitaxel (80 mg/m2) IV weekly for 12 doses"
Chungbuk university hospital, Cheonju
National Cancer Center, Goyang
National Health Insurance Service Ilsan Hospital, Ilsan
Bundang Cha Hospital, Seongnam
Ajou universwity Medical Center, Suwon
Soonchunhyang university Cheonan hospital, Cheonan
Inje University Haeundae Paik Hospital, Busan
Keimyung University Dongsan Medical Center, Daegu
Gachon University Gil Medical Center, Incheon
Seoul national university Bundang Hospital, Seongnam
Asan Medical Center, Seoul
Boramae Medical Center, Seoul
Catholic university of Korea, Seoul St. Mary's Hospital, Seoul
Chung Ang University Heaelthcare System, Seoul
Gangnam Severance hospital, Seoul
Korea University Anam hospital, Seoul
Kyunghee University Healthcare System, Seoul
Samsung Medical Center, Seoul
Yonsei Cancer Center at Yonsei University Medical Center, Seoul
Ulsan University Hospital, Ulsan
Wonju Severance Christian Hospital, Wŏnju
Yonsei University
OTHER